New heart device tested in humans for first time
NCT ID NCT06840509
First seen Feb 21, 2026 · Last updated Jun 22, 2026 · Updated 14 times
Summary
This early study tests the safety and performance of a new implantable defibrillator (the CorSky ICD) in 52 people who need one for heart failure or dangerous fast heart rhythms. Participants will be followed for 12 months to check for device-related problems. The device is programmed to each person's medical needs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Princess Alexandra Hospital
Brisbane, Australia
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CorSky ICD or CRT-D device
What this could lead to
If successful, this could lead to a new, safe option for implantable defibrillators that help control dangerous heart rhythms in people with heart failure.
What could go wrong
This is a very early, small study (52 people) focused only on safety and device function. It does not test whether the device improves health outcomes, and device-related complications are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.